Devices › Implantable pulse generator, pacemaker (non-crt)
Device brand name · Implantable pulse generator pacemaker non-crt
Energen Crt-D: medical device reports filed with FDA
672 reports name it, 2014–2026. Manufacturer given most often on reports: Boston Scientific. Product code LWP.
- 672
- device reports naming the brand
- 0% of all MAUDE reports · about 54 a year
- 6
- reports, 12 months to August 2026
- 35 in the 12 months before
- 32.3%
- classified as malfunction
- 41.5% across the product code
- 0.7%
- classified as death, as reported
- 5 reports · not verified by FDA
672 medical device reports received by FDA name the brand "Energen Crt-D" (implantable pulse generator pacemaker non-crt); the manufacturer given most often on reports is Boston Scientific; received from January 2014 to July 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
6 reports arrived in the 12 months to August 2026, down 83% from 35 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (67%), malfunction (32.3%) and death (0.7%); across all implantable pulse generator, pacemaker (non-crt) reports (product code LWP) death is recorded in 1.2% and malfunction in 41.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are premature discharge of battery (28.1%), high impedance (21.1%) and device displays incorrect message (18.9%). The patient problems coded most often are electric shock, sepsis and asystole. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 157,494 reports carrying product code LWP. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Premature discharge of battery | 189 | 28.1% | 22.3% |
| High impedance | 142 | 21.1% | 9% |
| Device displays incorrect message | 127 | 18.9% | 7.9% |
| Over-sensing | 64 | 9.5% | 8.4% |
| Pacing problem | 61 | 9.1% | 5.6% |
| Signal artifact/noise | 48 | 7.1% | 3.1% |
| Inappropriate/inadequate shock/stimulation | 46 | 6.8% | 0.9% |
| Defective devicethe device was defective | 41 | 6.1% | 3.5% |
| Battery problema problem with the battery | 37 | 5.5% | 3.4% |
| Noise, audible | 34 | 5.1% | 0.8% |
| Incorrect, inadequate or imprecise result or readings | 26 | 3.9% | 4.3% |
| Failure to capture | 22 | 3.3% | 5.3% |
| Device sensing problem | 20 | 3% | 2.2% |
| High capture threshold | 18 | 2.7% | 2.6% |
| Low impedance | 17 | 2.5% | 2% |
| Impedance problem | 7 | 1% | 0.9% |
| Interrogation problem | 7 | 1% | 1.3% |
| Defibrillation/stimulation problem | 5 | 0.7% | 0.2% |
| Under-sensing | 5 | 0.7% | 2.1% |
| Delayed charge time | 4 | 0.6% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Electric shockan electric shock | 32 | 4.8% |
| Sepsisa severe body-wide response to infection | 31 | 4.6% |
| Asystole | 9 | 1.3% |
| Shock from patient lead(s) | 9 | 1.3% |
| Muscle stimulation | 7 | 1% |
| Device overstimulation of tissue | 6 | 0.9% |
| Syncopefainting | 6 | 0.9% |
| Pocket erosion | 5 | 0.7% |
| Bradycardiaslow heart rate | 4 | 0.6% |
| Endocarditis | 4 | 0.6% |
| Hematomaa collection of blood under the skin or in tissue | 4 | 0.6% |
| Syncope/fainting | 4 | 0.6% |
| Deaththe patient died; cause not stated by this term | 3 | 0.4% |
| Dizzinesslight-headedness or unsteadiness | 3 | 0.4% |
| Ventricular fibrillationa chaotic rhythm from the lower heart chambers | 3 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Energen Crt-D | Product code LWP | All MAUDE reports |
|---|---|---|---|
| Reports | 672 | 157,494 | 26,136,888 |
| Share of that pool | — | 0.4% | 0% |
| Classified as death, per 1,000 reports | 7 | 12 | 9 |
| Classified as injury | 67% | 57.3% | 36.2% |
| Classified as malfunction | 32.3% | 41.5% | 62.3% |
| Filed by the manufacturer | 100% | 99.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LWP
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Assurity Mri | 18,995 | 2,035 | 1.8% |
| Teligen | 16,537 | 47 | 0.6% |
| Ingenio | 7,539 | 493 | 0.8% |
| Cognis | 8,694 | 6 | 1.5% |
| Ingevity | 9,039 | 299 | 0.9% |
| Accolade | 4,335 | 4 | 1.5% |
| Attain Otw | 7,773 | 0 | 9.1% |
| Energen | 5,237 | 0 | 0.6% |
| Energen Icd | 3,151 | 142 | 0.2% |
| ACUITY X4 Spiral S | 2,816 | 424 | 0.5% |
| ACUITY X4 Straight | 2,672 | 382 | 0.4% |
| Incepta Icd | 2,497 | 126 | 0.1% |
| Altrua | 4,122 | 0 | 2.4% |
| Incepta | 4,327 | 0 | 0.7% |
| Revo MRI SureScan | 1,996 | 12 | 2.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Energen Crt-D reports
How many FDA reports name Energen Crt-D?
672 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 6 in the latest 12 months.
What kinds of events are reported?
injury (67%), malfunction (32.3%) and death (0.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
premature discharge of battery (28.1%), high impedance (21.1%), device displays incorrect message (18.9%), over-sensing (9.5%) and pacing problem (9.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Energen Crt-D was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.